Patrick O'Brien, the COO of $ARWR, sold 4,368 shares of the company on 01-05-2026 for an estimated $267,321. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of their shares of this class of stock. Following this trade, they now own 520,033 shares of this class of $ARWR stock.
$ARWR Insider Trading Activity
$ARWR insiders have traded $ARWR stock on the open market 49 times in the past 6 months. Of those trades, 0 have been purchases and 49 have been sales.
Here’s a breakdown of recent trading of $ARWR stock by insiders over the last 6 months:
- CHRISTOPHER RICHARD ANZALONE (Chief Executive Officer) has made 0 purchases and 13 sales selling 175,944 shares for an estimated $11,661,762.
- JAMES C HAMILTON (Chief Medical Officer) has made 0 purchases and 12 sales selling 100,164 shares for an estimated $4,259,661.
- PATRICK O'BRIEN (COO) has made 0 purchases and 12 sales selling 49,493 shares for an estimated $3,123,349.
- MAURO FERRARI has made 0 purchases and 2 sales selling 16,280 shares for an estimated $1,020,512.
- MICHAEL S PERRY sold 16,250 shares for an estimated $991,737
- VICTORIA VAKIENER has made 0 purchases and 3 sales selling 10,040 shares for an estimated $679,491.
- ADEOYE Y OLUKOTUN has made 0 purchases and 3 sales selling 10,000 shares for an estimated $676,623.
- WILLIAM D. WADDILL has made 0 purchases and 3 sales selling 8,367 shares for an estimated $566,038.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ARWR Hedge Fund Activity
We have seen 169 institutional investors add shares of $ARWR stock to their portfolio, and 118 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRIEHAUS CAPITAL MANAGEMENT LLC added 2,099,398 shares (+inf%) to their portfolio in Q3 2025, for an estimated $72,408,237
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,017,489 shares (+3142.5%) to their portfolio in Q3 2025, for an estimated $69,583,195
- DEERFIELD MANAGEMENT COMPANY, L.P. added 993,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $34,248,570
- JANUS HENDERSON GROUP PLC added 923,722 shares (+1853.2%) to their portfolio in Q3 2025, for an estimated $31,859,171
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 834,661 shares (+31.1%) to their portfolio in Q3 2025, for an estimated $28,787,457
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 822,343 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $28,362,610
- BLACKROCK, INC. added 799,938 shares (+4.1%) to their portfolio in Q3 2025, for an estimated $27,589,861
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ARWR Analyst Ratings
Wall Street analysts have issued reports on $ARWR in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 12/17/2025
- Chardan Capital issued a "Buy" rating on 12/01/2025
- B of A Securities issued a "Buy" rating on 12/01/2025
- RBC Capital issued a "Outperform" rating on 11/19/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/08/2025
To track analyst ratings and price targets for $ARWR, check out Quiver Quantitative's $ARWR forecast page.
$ARWR Price Targets
Multiple analysts have issued price targets for $ARWR recently. We have seen 7 analysts offer price targets for $ARWR in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- Edward Tenthoff from Piper Sandler set a target price of $100.0 on 12/17/2025
- Luca Issi from RBC Capital set a target price of $80.0 on 12/11/2025
- Jason Gerberry from B of A Securities set a target price of $81.0 on 12/09/2025
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $85.0 on 12/02/2025
- Keay Nakae from Chardan Capital set a target price of $60.0 on 12/01/2025
- Michael Ulz from Morgan Stanley set a target price of $48.0 on 11/26/2025
- Andrea Tan from Goldman Sachs set a target price of $48.0 on 11/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
